Catalyst
Slingshot members are tracking this event:
Ionis Pharmaceuticals (IONS) to submit to EMA for Inotersen, which treats TTR amyloidosis, by end of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IONS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 01, 2018
Occurred Source:
http://ir.ionispharma.com/news-releases/news-release-details/akcea-and-ionis-receive-positive-eu-chmp-opinion-tegsedi
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ttr Amyloidosis, European Medicines Agency, Inotersen
